Beta-blocker, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, nitrate-hydralazine, diuretics, aldosterone antagonist, ivabradine, devices and digoxin (BANDAID2): an evidence-based mnemonic for the treatment of systolic heart failure
Author:
Affiliation:
1. NHMRC Clinical Trials Centre; University of Sydney; Sydney New South Wales Australia
2. Sydney Medical School; University of Sydney; Sydney New South Wales Australia
3. Royal Prince Alfred Hospital; Sydney New South Wales Australia
Funder
National Health and Medical Research Council
Sydney Medical School
Publisher
Wiley
Subject
Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/imj.12839/fullpdf
Reference42 articles.
1. 2011 Update to National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006;Krum;Med J Aust,2011
2. Adherence to treatment guidelines in the pharmacological management of chronic heart failure in an Australian population;Yao;J Geriatr Cardiol,2011
3. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines;Yancy;Circulation,2013
4. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012;McMurray;Eur J Heart Fail,2012
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Omega-3 supplementation and outcomes of heart failure: A systematic review of clinical trials;Medicine;2024-01-19
2. Adjunct Drug Treatment to Reduce Vascular Disease in People with Diabetes;Contemporary Diabetes;2023
3. Guideline‐based audit of the hospital management of heart failure with reduced ejection fraction;Internal Medicine Journal;2022-11-08
4. The exercise in pulmonary arterial hypertension (ExPAH) study: A randomized controlled pilot of exercise training and multidisciplinary rehabilitation in pulmonary arterial hypertension;Pulmonary Circulation;2022-04
5. Precision Medicine Approaches for Management of Type 2 Diabetes;Precision Medicine in Diabetes;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3